SYNBIO
SynBio is a long-term project started in 2011 with the goal of creating innovative medicines, including what are known as Biobetters. This project is a collaborative effort of several Russian and international pharmaceutical companies.
SYNBIO
Industry:
Health Care Pharmaceutical
Founded:
2011-08-01
Address:
Moscow, Moscow City, Russian Federation
Country:
Russian Federation
Website Url:
http://www.synbio-pharma.com
Status:
Active
Technology used in webpage:
Domain Not Resolving
Similar Organizations
InSysBio
InSysBio is a pharmalogical company.
Nevrargenics
Nevrargenics is a pharmaceuticals based company.
Nolla Antimicrobial
Nolla Antimicrobial is a Pharmaceutical company
OJSC Biosintez
OJSC Biosintez is a pharmaceuticals company.
OncoTherics
Oncotherics is a pharmaceuticals company.
Orion Pharma
Orion Pharma is a pharmaceutical company.
Pliva
Pliva is the largest pharmaceutical company in Croatia.
Synthélabo
It is a pharmaceutical company
Official Site Inspections
http://www.synbio-pharma.com
Unable to get host informations!!!
More informations about "SynBio"
Organization Chart - About SymBio - SymBio ... - SymBio Pharma
Nov 21, 2024 Organization chart Diverse ties with individuals and companies will strengthen our business foundation and expand our activities. In addition to the Scientific Advisory Board and …See details»
Canada SynBio Conference
Canada SynBio 2024 Conference - #SynBio2024 - is Canada’s premier engineering biology event and will take place in Toronto on October 7-9, 2024 This one-of-a-kind conference brings together national and international …See details»
SymBio Pharmaceuticals
Notice of Personnel Changes at SymBio Pharma USA, Inc. 2023.06.12 Presentation of the Results of Biomarker Research Predicting the Antitumor Effects of Brincidofovir at the 17th …See details»
Company Profile - About SymBio - SymBio Pharmaceuticals …
Mar 25, 2005 name: SymBio Pharmaceuticals Limited: English name: SymBio Pharmaceuticals Limited: location: Toranomon Towers Office, 7th floor, 4-1-28 Toranomon, Minato-ku, Tokyo …See details»
SynBio Canada
Nov 15, 2024 SynBio Canada aims to establish Canada as a leader in the field of synthetic biology, by bringing together academics, industry partners, and the general public to learn and collaborate.See details»
Board of Directors — SynBio Canada
Which is why he founded SynBio Canada in 2018, to create a strong national community, and to develop and retain expertise across the country. He holds a BSc, MSc, and PhD with …See details»
SynBio - Crunchbase Company Profile & Funding
SynBio is a long-term project started in 2011 with the goal of creating innovative medicines, including what are known as Biobetters. This project is a collaborative effort of several Russian …See details»
Our Vision & Mission — SynBio Canada
How we will accomplish Our mission. Community build: Create a visible and connected community of researchers and enthusiasts Fund: Provide financial support for the Canadian …See details»
SynBio Company Profile 2024: Valuation, Funding
SynBio General Information Description. Developer of a biotechnology platform designed to create innovative new medicines known as Biobetters. The company's biotechnology platform engages in the development, …See details»
How Do We Unite Synbio and Pharma? Insights from …
Jun 14, 2023 Synbio is creeping into managing costs and improving efficiencies, and increasing the probability of success. The real, high-value impact of synbio is going to be in therapeutics. Pharma tends to be asset-centric when looking at …See details»
Pharma’s use of synthetic biology could deliver radical …
2 days ago Synthetic biology holds much promise for the life sciences sector as it continues to look for new ways of treating disease and accelerating drug development, says Debiopharm's Tanja Dowe.See details»
SymBio announces commencement of operations of SymBio
SymBio Pharma USA, Inc. TOKYO, Japan, October 12, 2021 -- SymBio Pharmaceuticals Limited (Headquarters: Tokyo, "SymBio" or the “Company”) today announced the appointment of Dr. …See details»
AGENDA - CanadaSynBio Site
Oct 7, 2024 Canada SynBio 2024 Conference offers a series of engaging presentations, dynamic workshops, on demand videos, and interactive networking events. MONDAY, …See details»
Esphera SynBio | Source From Ontario
Esphera SynBio is a pre-clinical company developing the next generation of exosome-based therapeutics. Their proprietary technology enables the generation of bespoke exosomes by …See details»
Is Pharma Finally Catching on to SynBio? - SynBioBeta
Mar 1, 2024 For years, the synbio industry has tried to raise awareness of its capabilities to pharma leaders. Success has been uneven at best. While modalities like mRNA and cell and …See details»
Synthetic Biology: A Potential Game-Changer for the Biopharma …
It is generally thought that measurable investment in synthetic biology will occur over the next 5–10 years, but it will take time for the conservative biopharma industry to fully embrace …See details»
IR News & Topics - News - シンバイオ製薬株式会社 SymBio …
Aug 7, 2024 Message from President of SymBio Pharma USA 2021.10.12 SymBio announces commencement of operations of SymBio Pharma USA, Inc. 2021.09.29 SymBio announces …See details»
Where Can Biopharma Best Leverage Synbio Today?
Jul 26, 2023 Earlier this year, I wrote about the J.P. Morgan Conference in San Francisco and what it taught me about the state of synbio in (or out) of biopharma.Based on what I saw there, …See details»
Ginkgo Bioworks and Novo Nordisk are Shifting the SynBio …
Oct 2, 2023 “Biopharma and synbio are not diametrically opposed like the current narrative portrays. Most of biopharma is doing synbio and has been for a while. The change is using the …See details»
SynBio and Bio Convergence: Israeli Tech Transforming Global …
Nov 17, 2024 In your opinion, how do SynBio and bio convergence intersect with high-tech sectors like climate, agrifood, health, materials, energy, especially in Israel’s tech-driven …See details»